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Abstract
Cre/LoxP recombination is the gold standard for conditional gene regulation in mice in vivo. However, promoters driving
the expression of Cre recombinase are often active in a wide range of cell types and therefore unsuited to target more
specific subsets of cells. To overcome this limitation, we designed inactive ‘‘split-Cre’’ fragments that regain Cre activity
when overlapping co-expression is controlled by two different promoters. Using transgenic mice and virus-mediated
expression of split-Cre, we show that efficient reporter gene activation is achieved in vivo. In the brain of transgenic mice,
we genetically defined a subgroup of glial progenitor cells in which the Plp1- and the Gfap-promoter are simultaneously
active, giving rise to both astrocytes and NG2-positive glia. Similarly, a subset of interneurons was labelled after viral
transfection using Gad67- and Cck1 promoters to express split-Cre. Thus, split-Cre mediated genomic recombination
constitutes a powerful spatial and temporal coincidence detector for in vivo targeting.
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Introduction
The central nervous system (CNS) as the most complex organ in
mammals is composed of a large variety of heterogeneous cell
populations. To characterize distinct cell types, neuroscientists
take advantage of the fact that many neuronal and glial subsets can
be defined by the expression of a unique combination of genes.
Broadly expressed cell markers, such as the neuronal nuclei
antigen NeuN, the glial fibrillary acidic protein (GFAP), myelin
proteolipid protein (PLP) and the fractalkine receptor CX3CR1
(which identify neurons, astrocytes, oligodendrocytes and microg-
lia, respectively), are commonly used in immunohistochemical
analysis of brain development or disease. Moreover, a plethora of
transgenic mice has been generated, in which the promoters of
these and other ‘‘cell type-specific’’ genes drive the expression of
fluorescent proteins or Cre recombinase in the nervous system.
The Cre/LoxP system [1] has been extensively used for cell fate
mapping [2–5] and numerous studies exist in which Cre/loxP was
usedtoanalysethecell-typespecificfunctionofagenebyconditional
gene ablation or induction [6,7]. This includes analysis of
mechanisms of spatial memory in CA1 neurons of the hippocampus
or the function of peroxisomes in oligodendrocytes [8,9].
Despite this impressive success of cell-specific gene targeting and
recent progress in the temporal control of Cre activity [10], the
expression pattern of a single promoter activity is often insufficient
to genetically define a distinct neural cell type [11]. To overcome
this limitation of Cre/LoxP-mediated DNA-recombination, we
added a second dimension of recombination control by designing
a novel ‘‘split-Cre’’ system based on the complementation of Cre
protein fragments. For this purpose, we constructed fusion proteins
of a constitutive protein-protein interaction domain with either N-
or C-terminal Cre fragments (designated NCre and CCre,
respectively). We selected the GCN4-coiled coil domain as the
interaction domain since it has been shown to form stable dimers
[12] and to enable functional complementation of dihydrofolate
reductase in vitro and in E. coli [13] as well as of tobacco etch virus
protease in vitro [14]. Each of these split-Cre proteins alone was
unable to catalyse DNA recombination. However, they readily
assembled into a functional enzyme when co-expressed in the
same cell in vivo in transgenic mice, or by viral infection. Using a
Cre-reporter mouse strain we demonstrate that Cre activity
persistently labels cells defined by transient, but coincident
expression of NCre and CCre during embryogenesis. Split-Cre
is thus a versatile tool to study transient cell populations during
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4286development and disease processes and to precisely genetically
target distinct cell populations in the CNS as shown here, but
additionally in other organs.
Results
Generation of split-Cre-proteins
To establish a Cre-based complementation system (‘‘split-
Cre’’), which allows recombination of LoxP-flanked DNA
sequences depending on the simultaneous activity of two
promoters (Fig. 1A), the coding sequence of Cre recombinase
was cut into two complementation-competent fragments [15,16]
coding for amino acids residues 19–59 and 60–343. Both Cre
fragments were fused to the constitutively dimerizing coiled-coil
leucine zipper domain of the yeast transcriptional activator
GCN4 [12] to force the association of split-Cre fragments,
thereby enhancing Cre activity by functional complementation.
In addition, immunotags, a semi-flexible linker and a nuclear
localization sequence were added to both Cre fragments. The
resulting split-Cre fusion proteins were named NCre and CCre,
respectively (Fig. 1A, B). Functional complementation of these
constructs was tested first in COS, CHO and PC12 cells. High
recombination efficiency was observed whenever both NCre and
CCre proteins were co-expressed, while no recombination was
detected when either NCre or CCre were expressed alone
(Fig. S1).
Functional complementation of split-Cre in vivo
To analyse whether split-Cre complementation induces
recombination activity in vivo, we generated transgenic mice
expressing NCre and CCre under the control of the mouse
proteolipid protein (PLP) and the human glial fibrillary acidic
protein (GFAP) promoter (see Fig. S2A for transgene constructs).
These glial promoters were selected since previous fate-mapping
studies of glial lineages demonstrated PLP- as well as GFAP-
promoter activity in progenitor cells during fetal development of
the brain. It is, however, not clear whether this occurs in the
same cells or in different population of progenitor cells. We
obtained three lines of PLP-NCre-mice (PCNA, PCNC, PCND),
two lines of PLP-CCre mice (PCCK, PCCR), four lines of
GFAP-NCre- (GCNQ, GCNT, GCNV, GCNW) as well as one
GFAP-CCre-mouse line (GCCF) (Text S1). Successful comple-
mentation and functional recombination was detected in triple-
transgenic mice (using the reporter line ROSA26-LoxP-Stop-
LoxP-EYFP [17]; ROSY) when (1) both NCre and CCre were
targeted to oligodendrocytes by the PLP promoter (Fig. 1C–E;
Fig. S3) or when (2) both fragments were expressed in astrocytes
driven by the GFAP promoter (Fig. 1F–H; Fig. S5). For
comparative evaluation of split-Cre vs. full-length Cre induced
recombination in transgenic mice, founder-dependent line-to-
line variability of expression patterns inherent to mouse
transgenesis has to be considered. This variation affects split-
C r em o r et h a nn o r m a lC r e - m i c ed u et ot h en e e do ft w o
transgenes. Taken these idiosyncrasies into account, split-Cre
revealed a similar pattern and extend of reporter gene expression
(Fig. S3, S4 and S5; and compare to [2–4,18]). The slightly
reduced number of recombined cells in PLP-NCre x PLP-CCre
mice compared to the maximal recombination achievable in
PLP-Cre mice (Fig. S3, S4) can be attributed to not completely
overlapping expression patterns of the PLP-NCre and PLP-CCre
transgenes in the respective mouse lines. Therefore, we conclude
that the NCre/CCre complex catalyzes DNA-recombination in
cells co-expressing both proteins.
Distinct populations of glial progenitors identified by Cre
complementation
Previous fate-mapping studies have shown that Cre-dependent
recombination driven by GFAP or PLP promoters during
embryonic development labels distinct glial and neuronal cell
populations [2–4,18]. Here, we asked whether both promoters are
active in separate lineages or whether coincident activity can
highlight a distinct neural cell type or cellular subpopulation. For
that purpose, we analysed the Cre-complementation of the GFAP-
NCre and PLP-CCre transgenes in ROSY reporter mice (Fig. 2).
We could identify Cre-induced EYFP expression in various brain
regions. Co-immunostaining for the reporter EYFP and the
astroglia marker protein S100b together with distinct morphology
revealed that most of the cells in which recombination had taken
place were bona fide astrocytes (Fig. 2). Interestingly, the
recombination pattern suggested that cerebellar Bergmann glial
cells as well as a glial population at the juxtaventricular zone were
derived from progenitors with simultaneous GFAP- and PLP-gene
activity (Fig. 2A–F). We counted the fraction of EYFP-labeled
Bergmann glial cells as a percentage of all S100b-positive cells in
the Purkinje cell layer of the cerebellum and found 2568%
labeled cells (mean6sd; n=4 mice; 400 cells counted in total). In
contrast, cortex (Fig. 2J–L), hippocampus, striatum or cerebellar
white matter (Fig. S6) showed only a few labeled cells.
Interestingly, another radial glial cell type, the Mu ¨ller cells of
the retina, exhibited a similarly high recombination frequency as
the Bergmann glia (Fig. 2G–I). Although labeled cells were mainly
identified as astrocytes, we also detected throughout the brain of
all transgenic crossings cells, which were identified as NG2 glia
due to their expression of the chondroitin sulphate proteoglycan
NG2 [19–21] (Fig. 2M–O).
To identify the developmental stage when the PLP- and GFAP
promoters are active in the same cell, we stained brain tissue for
EYFP-expression at different time points during development.
While no reporter expression could be detected at E12.5 and
E15.5 (data not shown), EYFP positive cells could be detected at
embryonic day 18.5 (E18.5) in the juxtaventricular zone close to
the dorsal 3
rd ventricle (Fig. 2P), the cerebellum (Fig. 2R) and in
the midbrain (data not shown). By postnatal day 2 (P2), the cells in
the cerebellum and in the midbrain acquired the typical
morphology of Bergmann glial cells and astrocytes, respectively
(Fig. 2S).
In conclusion, these experiments demonstrate that split-Cre
reports coincident gene activities in vivo. Functional complemen-
tation of N- and C-terminal Cre fragments is achieved even when
co-expression of both peptides is only transient due to the control
by distinct promoter elements.
Interneurons expressing GAD67 and CCK can be targeted
by split-Cre in vivo using adeno-associated viruses
Due to its flexibility viral infection has become a common tool
to genetically label or modify cells in vivo. In contrast to transgenic
mice, viruses can be generated fast and can also be applied at
defined time points of development or disease progression.
Therefore, we decided to test whether the split-Cre fragments
would be able to functionally recombine when introduced by
adeno-associated viral (AAV) vectors. In this set of experiments we
focussed on interneurons, since the identification of interneuron
subpopulations is difficult [22,23]. As interneuronal promoter
elements, we selected those for the GABA-synthesizing enzyme
glutamate acid decarboxylase (GAD67) and for the neurohormone
cholecystokinin (CCK; see Fig. S2B for viral constructs). For
control purposes, we first tested whether mixtures of viruses
Split-Cre In Vivo
PLoS ONE | www.plosone.org 2 January 2009 | Volume 4 | Issue 1 | e4286Figure 1. A: Principle of split-Cre complementation. NCre- and CCre-coding sequences are placed under the control of two different promoters
(promoter 1 and 2, respectively). Only if both promoters are active, functional complementation takes place and LoxP (red triangles) – flanked
sequences are recombined, thereby activating reporter genes (A1) or excising exons for knock-out strategies (A2). Ubi: ubiquitously expressed
promoter (in our study the ROSA26 promoter). B: Design of fusion proteins. NCre- and CCre-proteins were constructed by fusing amino acids 19–
59 (NCre) or amino acids 60–343 (CCre) of the sequence of Cre recombinase to the constitutive active coiled-coil interaction domain of the yeast
transcription factor GCN4 (GCN4cc). Immunotags (Flag, Myc), a linker sequence as well as a nuclear localization sequence (NLS) were also added. C–H:
Functional complementation of Cre activity in transgenic mice. C–E: NCre and CCre were transgenically expressed in mice using the PLP
promoter. Transgenic mouse lines expressing NCre (line PCND) and CCre (line PCCR) were crossed to ROSY reporter mice and analysed for
recombination with in the corpus callosum (C). Slices were counterstained with the oligodendroglial marker CC1 (D). The overlay is shown in E.
Arrows point to examples of CC1-positive oligodendrocytes, which show also expression of the EYFP reporter. F–H: NCre and CCre were
transgenically expressed in mice using the GFAP-promoter. Transgenic mouse lines expressing NCre (line GCNV) and CCre (line GCCF) were crossed to
ROSY reporter mice and analysed for recombination in the cerebellum (F). Bergmann glia cells were stained with antibodies against S100b (G). The
overlay is shown in H. Arrows highlight S100b-positive cells which show recombination. The scale bar in H corresponds to 50 mm and applies to
panels C–H.
doi:10.1371/journal.pone.0004286.g001
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PLoS ONE | www.plosone.org 3 January 2009 | Volume 4 | Issue 1 | e4286Figure 2. A combination of PLP- and GFAP-promoter drives recombination mainly in astrocytes and NG2-cells. Transgenic mouse lines
expressing NCre under the GFAP promoter and CCre under the control of the PLP promoter were crossed to ROSY-reporter mice and analysed for
recombination in different brain regions (A, D, G, J, M). Slices were counterstained using the astroglial marker S100b (B, E, K), the Mu ¨ller cell marker
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label the respective cell type. For comparison, we also used
mixtures of GFAP-NCre and GFAP-CCre encoding AAV viruses
and detected specific recombination in many GFAP-positive
astrocytes of the injected region (Fig. S7A–F). Similarly, co-
injection of GAD67-NCre and GAD67-CCre viruses into the
hippocampus resulted in the labelling of interneurons of which a
subpopulation could be immunostained with the marker parval-
bumin (Fig. S7G–L). Finally, co-injection of CCK-NCre and
GAD67-CCre viruses into the hippocampus resulted in recombi-
nation in interneurons which could be labelled by parvalbumin
(Fig. 3A–C) as well as by calretinin (Fig. 3D–F). No recombination
could be observed when NCre- or CCre expressing viruses were
injected alone, irrespective of the regulatory element used to drive
the expression (data not shown). These data thus show that adeno-
associated viral vectors can be successfully used to transfer split-
Cre fragments. The split-Cre system is thus a powerful tool for
inducing DNA-recombination in vivo and targeting cell populations
defined by the simultaneous expression of two genes.
Discussion
Split-Cre: A powerful new tool for mouse genetics
Our novel split-Cre complementation system introduces a
second dimension to the cell-type specific control of DNA-
recombination in vivo. We divided the Cre recombinase into two
fragments and fused both to strong protein interaction domains.
The resulting fusion proteins (termed NCre and CCre) were able
to complement each other thus reconstituting functional Cre
recombinase in neurons and glia of a living mouse. Transgenic co-
expression of NCre and CCre and subsequent functional
complementation induced a pattern of reporter gene expression
as observed with intact Cre recombinase driven by the same
promoters. In transgenic as well as in virus-infected animals,
distinct cell populations defined by simultaneous activity of two
different genes were targeted. The coincident detection of gene
activities combined with efficient, permanent DNA-modification
makes our approach a useful extension of existing DNA
recombinase based methods. In combination with the plethora
of existing mouse lines with LoxP-flanked genes, split-Cre provides
a unique platform, which will allow more sophisticated genetic
experiments to analyze cell lineage or cell heterogeneity in the
future.
Technical considerations
Functional complementation of split proteins is a powerful
approach and has already been widely used for the analysis e.g. of
protein-protein-interactions. The functional, bimolecular comple-
mentation of diverse proteins such as the green fluorescent protein
(GFP), firefly luciferase, dihydrofolate reductase, b-galactosidase or
tobacco etch virus protease has become an important assay system
in vitro [24]. The reconstitution of fluorescent protein fragments
has become particularly important since the formation of the
functional protein complex can be directly visualized in living cells
Figure 3. Functional complementation of split-Cre in vivo after viral infection. Adeno-associated viral vectors (AAV) containing NCre or
CCre under the control of the CCK- and GAD67-promoter, respectively, were injected into brains of ROSY reporter mice and recombination was
analysed by EYFP expression. A population of interneurons showing DNA recombination was identified (A, D) that express either parvalbumin (B,
arrow) or calretinin (E, arrow). Arrowheads mark cells which are positive for the respective marker protein, but show no recombination. The scale bar
in F corresponds to 50 mm and applies to all panels. DG: dentate gyrus; hc: hippocampus.
doi:10.1371/journal.pone.0004286.g003
cellular retinaldehyd binding protein (CRALBP; H) as well as NG2 (N). Overlays are shown in C, F, I, L and O. Most cells showing recombination in these
mice stain also for the astroglial marker (examples are marked by arrows in A–L). A subpopulation of EYFP-labeled cells is positive for NG2 (arrow in
M–O), but not all NG2 cells express the reporter EYFP (arrow head in M–O). P–S: Developmental appearance of labeled cells in the juxtaventricular
zone close to the dorsal 3
rd ventricle (P, Q) and in the cerebellum (R, S). Shown are examples from embryonic day 18.5 (P, R) and postnatal day 2 (Q, S).
The dotted lines in P, Q show the approximate border of the ventricle. Mouse lines GCNV x PCCK (G–I); GCCF x PCND (M–O), GCNT x PCCK (P–S) and
GCNT x PCCR (all others) were used for this analysis. The scale bars in O and S correspond to 50 mm and apply to panels A–O and P–S, respectively.
d3V: dorsal third ventricle; GrDG: granular layer of the dentate gyrus; Th: thalamus; cb: cerebellum; ctx: cortex.
doi:10.1371/journal.pone.0004286.g002
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constitutes only a transient signal [27]. In contrast, stable and
long-lasting labeling and modification of cells by DNA-recombi-
nation can be achieved using fragment complementation based on
the Cre/LoxP system.
For forced dimerization of the Cre fragments, we selected a
yeast interaction domain to decrease the risk of interaction with
endogenous murine coiled-coil proteins. For example, GCN4
coiled-coil domains do not interact with c-myc of the host [28].
Although we cannot exclude the possibility that our constructs
bind to endogenous proteins and interfere with cellular physiology,
we did not observe any abnormalities in the transgenic mice
generated, with respect to cage behaviour, breeding performance
and expression of marker proteins. Therefore, split-Cre comple-
mentation by itself does not appear to alter mouse physiology.
Previously, Cre fragments have been fused to FKBP12 (FK506-
binding protein) and FRB (binding domain of the FKBP12-
rapamycin-associated protein) for dimerization [15,16]. However,
to induce binding here, rapamycin must be used which is
disadvantageous for two reasons: (1) it is an immunosuppressant
and can interfere with animal physiology; (2) its use for analysis of
the CNS is limited due to its poor ability to traverse the blood
brain barrier. Indeed, no recombination was observed within the
brain [16].
The detection and extend of functional Cre complementation is
determined by several parameters which have to be considered
carefully for interpretation of data:
(1) Temporal relations within the split-Cre system. While the cell-
specific expression levels of NCre and CCre is primarily
determined by the activities of the chosen promoters, the
visualization of complementation depends on the kinetics of
complementation, DNA recombination, reporter gene tran-
scription and translation as well as the time needed to
accumulate enough reporter protein to allow detection.
Furthermore, after cessation of short-lived promoter activities
remaining split-Cre mRNA and protein could evoke DNA
recombination even in the absence of promoter activity. From
our in vitro data and our experiences with recombination
induction and reporter detection in the tamoxifen-inducible
CreERT2/loxP system [29], we estimated a temporal
resolution of about 1 to 2 days for the split-Cre system.
(2) Specificity of transgenic or viral expression. It is a common
observation that mouse lines generated with the same
transgene construct can differ in their expression and show
a mosaic pattern. This is mainly attributed to the site and copy
number of integration of the transgene within the genome.
This mouse line-to-mouse line variability is potentiated in the
split-Cre system, since two mouse lines are needed for
functional complementation of NCre and CCre, and could
result in underestimation of complementation. Indeed, when
we directly compared the pattern of recombination in split-
Cre (PLP-NCre x PLP-CCre) and full-length Cre (PLP-Cre)
transgenic mice, less recombined cells were detected in split-
Cre mice (Fig. S3, S4). Similarly, expression of Cre fragments
after viral infection is strongly determined by viral serotype
and infection rate as well as the activity of chosen promoter
elements.
(3) Efficiency of split-Cre complementation. The efficiency of
split-Cre complementation in vitro was lower than that of full-
length Cre (Fig. S1); similar as shown for different Cre-
fragments in vitro [15,30,31]. In instances of very short
coincident activity of the two promoters, this might cause
decreased rates of recombination. Therefore, split-Cre might
underestimate the amount of cells with synced promoter
activities. But, cells that show DNA-recombination co-
expressed NCre and CCre, since in mice expressing only
either NCre or CCre no recombination could be observed.
(4) Specificity of reporter gene expression. The analysis of Cre
mediated recombination depends on the reliability of labelling
in the reporter mouse strain used. For example, it has been
shown for another ROSA26-based reporter line (ROSA26-
loxP-STOP-LoxP-LacZ) [32] that this labels differentiated
astrocytes poorly [2,4]. Therefore, we cannot exclude a biased
(i.e. reduced) reporter gene expression in our (ROSA26-loxP-
STOP-LoxP-EYFP) ROSY reporter even after successful
recombination. This again would result in underestimation of
the fraction of astrocytes with recombination. Since abundant
recombination in oligodendrocytes and neurons could be
detected in the PLP-NCre x PLP-CCre- and the PLP-Cre
mice with the same ROSY reporter allele, we can think it
highly unlikely that these cell types might have been targeted
in GFAP-NCre x PLP-CCre mice, but were not observed due
to poor expression of the ROSY reporter allele.
Split-Cre complementation can be broadly applied
We used two independent strategies to express split-Cre protein
fragments in the brains of living mice. First, NCre and CCre were
expressed in mice as transgenes driven by the PLP- [33,34] and
the GFAP-promoter [35,36]. While this approach leads to a stable
expression pattern, the generation of transgenic mice is expensive
and time consuming. Therefore, we also tested NCre and CCre
complementation in adeno-associated virus-mediated gene trans-
fer [37]. When NCre- and CCre were expressed under the control
of GAD67 and CCK promoters, functional complementation of
split-Cre could be achieved in a subset of interneurons. Therefore,
we conclude that split-Cre complementation can be broadly
applied and is independent of the expression method as well as the
cellular context.
A major strength of split-Cre is its versatility for different
experimental approaches due to its unique combination of
features, which has not been reported for any other technology
so far. Fate mapping experiments based on the overlapping
activity of two promoters have been performed previously by using
two independent recombinases (Cre and Flp) driven by two
promoters combined with a special reporter allele (for review:
[38]). This system has been used to analyse the development of
several brain regions [39–41]. Unfortunately, this strategy is
limited to fate mapping rather than the generation of knockout
mice by the need for special reporter alleles which is not
compatible with the numerous mouse lines harboring LoxP-
flanked genes. Xu et al. expressed Cre-fragments fused to
antiparallel leucine-zipper peptides in the pancreas using the
same Pdx1-promoter for both fragments [31]. Jullien et al. used
constitutive active promoters to drive the expression of rapamy-
cine-sensitive fusion proteins of Cre fragments, generating a new
version of inducible Cre. However, this approach is ineffective in
the brain since the blood-brain barrier is poorly permeable to
rapamycin [16]. Therefore, our study is to the best of our
knowledge the first showing DNA recombination induced by
complementation of inactive Cre-fragments expressed from two
different cell type specific promoters in transgenic mice as well as
after adeno-associated viral gene transfer. We prove the
widespread applicability to the central nervous system by using
two different pairs of DNA regulatory elements which are active in
neurons or glia, respectively. Our split-Cre system is ideally suited
to be combined with standard LoxP-reporter alleles for lineage fate
Split-Cre In Vivo
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induced diphtheria toxin expression [17,32,42,43]. Furthermore, a
protein of interest can be expressed from appropriate transgenes
using LoxP-flanked STOP-cassettes [6]. Finally, split-Cre is also
compatible with the increasing number of mouse lines harboring
LoxP-flanked genes for conditional knock-out studies [6].
A cell population characterized by simultaneous activity
of the GFAP- and the PLP-promoter
To evaluate the potency of split-Cre, we analyzed the progeny
of GFAP+/PLP+ cells during brain development using the GFAP-
NCre x PLP-CCre-mice. These results were compared to the
descendants of GFAP-positive as well as PLP-positive cells during
brain development, which have been analyzed in detail before
[2,3]. Using PLP-Cre as well as GFAP-Cre mice two phases of
embryonic cell differentiation were identified. During early
development (E11–E14) embryonic radial glia are neurogenic,
while in a later phase after E16 radial glia are gliogenic [2–4].
Since the PLP- as well as the GFAP-promoter is already active in
the early phase, PLP-Cre and GFAP-Cre mice activate reporter
genes in both neurons and glia [2–4]. Driving split-Cre expression
by either the PLP- or the GFAP- promoter reproduced these
findings. However, in GFAP-NCre x PLP-CCre mice split-Cre
complementation resulted in recombination only in glia (astrocytes
and NG2 glia) and not in neurons. This suggests that either two
types of embryonic neural progenitors exist or that the PLP+/
GFAP+ cells are generated at a late stage of development, when
the neuronal lineage is already separated from the glial lineage,
e.g. during the differentiation of PLP+ glia progenitors [3] to
astrocytes. The latter is supported by the finding that cells
expressing the reporter EYFP appear around E18. In addition, the
recombination observed in astrocytes (also in cerebellar Bergmann
glia and retinal Mu ¨ller cells) hints towards a role of oligodendrog-
lial genes (PLP) in early astroglia differentiation, supporting the
idea of PLP+ glia progenitors, which give rise to astrocytes [3].
In addition to astrocytes, we find recombination in NG2+ cells
of GFAP-NCre x PLP-CCre mice. NG2+ cells have been referred
to as oligodendrocyte precursor cells for a long time, but very
recent evidence suggests that NG2+ cells (besides numerous other
functions [44]) generate oligodendrocytes as well as gray matter
astrocytes in vivo, the latter most likely via a transition state which is
NG2+/GFAP+ [45]. Furthermore, in PLP-EGFP transgenic mice,
two populations of NG2+ cells have been described, one
expressing the PLP-EGFP transgene, the other being negative
for EGFP [46]. Therefore, it is tempting to speculate that the
astrocytes, which we found to be labeled in GFAP-NCre x PLP-
CCre-mice might be descendants of a NG2+/PLP+ cell
population [46], which activates transcription from the GFAP-
promoter during differentiation to the astrocytic lineage. While
this hypothesis remains to be analyzed in further experiments,
split-Cre offers a direct tool to test it by expressing one Cre-
fragment under the control of the NG2-promoter [45] and
combining these mice with mice expressing the other Cre-
fragment under the PLP- as well as the GFAP-promoter, thereby
highlighting the powerful potential of split-Cre for the analysis of
cell lineages during development.
Concluding remarks
We present here a powerful tool which allows selective genetic
targeting of cell populations defined by the simultaneous activity of
two promoters in the mouse, thereby adding a second dimension
of cell-type specific control to Cre-based conditional mouse
genetics. In addition, split-Cre can be used as a genetic
coincidence detector, which converts a temporal co-activity of
two promoters in a permanent readout. The split-Cre systems
allows for a more precise ‘genetic access’ [47] of (sub-) populations
of cells, which will offer advanced analysis of gene and cell
function in the mouse brain, as well as in other organs.
Materials and Methods
Ethics statement
Mouse breeding in the animal facilities of the Max-Planck
Institute of Experimental Medicine and animal experiments
including viral infections were performed according to European
and German guidelines for the welfare of experimental animals.
Cloning of split-Cre fusion proteins
The N- (aa 19–59) and C-terminal (aa 60–343) parts of iCre
recombinase [48] were PCR amplified, fused to the GCN4 coiled-
coil domain [14], a flexible linker (ASPSNPGASNGS; [15]) and a
nuclear localisation sequence and cloned into pCMV-Tag-2B or
pCMV-Tag-3B (Stratagene, La Jolla, CA, USA), respectively
(Fig. 1B). These fusion proteins are referred to as NCre and CCre,
respectively. See Supporting Information for details.
Generation of transgenic mice
Transgenic mice were generated using standard procedures.
The expression cassettes encoding NCre and CCre were cloned
into well characterised transgene vectors [49]. To drive the cell-
specific expression we used regulatory elements from the following
genes: gfap (homo sapiens, astrocytes, [35]), plp1 (mus musculus,
oligodendrocytes, [33]). Linearized transgenes were injected into
the pronucleus of fertilized oocytes obtained from FVB/N-mice.
Transgenic animals were crossed to ROSA26-LoxP-STOP-LoxP-
EYFP-reporter mice (ROSY; [17]) and recombination was
analysed in triple-transgenic animals containing the NCre-, CCre-
as well as the reporter allele. See Supporting Information Text S1
for details.
Generation of adeno-associated viruses
NCre and CCre were separately constructed into recombinant
AAV (rAAV) vector plasmid (pAAV-6P-SEWB; [50]), and driven
by regulatory elements of the following genes: cholecystokinin, cck
(mus musculus, 3.0 kb, interneurons), glutamic acid decarboxylase
1, gad1 (mus musculus, 3.0 kb, interneurons, GAD67) and gfap
(homo sapiens, 2.2 kb, astrocytes). A cross-packaging of AAV
serotype 1 and serotype 2 were performed by triple-transfection of
either NCre and CCre type of rAAV vector plasmid and both p-
DP1 and p-DP2 plasmids that express the AAV2 rep and cap
genes as well as the adenovirus E4, VA, E2a helper regions into
HEK 293 cells [37,51]. Virus was harvested by three times
freezing and thawing as described before [37].
Injection of adeno-associated viruses
Mice were anesthetized using either ketamine (87 mg/kg body
weight) and xylazine (13 mg/kg body weight) or avertin (275 mg/
kg body weight). Mice were placed into a stereotactic device and
500 nl of a NCre and CCre virus containing solution were injected
into the cortex or hippocampus. After surgical dressing, mice were
allowed to recover and reporter gene expression was analysed 14
to 21 days later.
Immunohistochemistry
Immunohistochemistry on vibratome slices of paraformalde-
hyde-fixed tissue was performed using standard procedures as
described [29,49] and imaged using confocal laser scanning
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GFP-antibodies (showing expression of the reporter gene EYFP)
are shown in green irrespectively of the fluorophor used for
detection of the antigen. See Supporting Information Text S1 for
antibodies and details.
Supporting Information
Figure S1 Functional complementation of NCre and CCre in
vitro. A: COS1 cells were transfected either with control plasmids
(mock), the reporter plasmid CMV-LoxP-STOP-LoxP-EGFP
(reporter) or the reporter in combination with full-length Cre (full
Cre), NCre or CCre alone or NCre+CCre. Recombination events
were monitored using flow cytometry. B: CHO cells were
transfected either with control plasmids (mock), the reporter
plasmid CMV-LoxP-STOP-LoxP-Luciferase (reporter) or the
reporter in combination with full-length Cre (full Cre), NCre or
CCre alone or NCre+CCre. Recombination events were moni-
tored using luciferase activity. C: PC12 20.4 cells, which contain a
stably integrated CMV-LoxP-STOP-LoxP-EGFP-reporter cas-
sette were transfected either with control plasmids (mock), full-
length Cre (full Cre), NCre or CCre alone or NCre+CCre.
Recombination events were monitored using flow cytometry
scoring for EGFP expression. The figure shows representative
experiments (mean6SD; n=3). All experiments were replicated at
least 3 times showing similar results.
Found at: doi:10.1371/journal.pone.0004286.s001 (0.11 MB TIF)
Figure S2 Transgene constructs and adeno-associated viral
constructs. A: Transgene constructs used for expression of split-
Cre in vivo (1: PLP-NCre; 2: PLP-CCre; 3: GFAP-NCre; 4:
GFAP-CCre). Due to the very different size of the constructs, the
schemes are not scaled. PLP-constructs were linearized using ApaI
and SacII, GFAP-constructs using DraIII and ApaLI prior to
mouse oocyte injection. B: Constructs for expression of split-Cre
using adeno-associated viruses. NCre and CCre were placed under
the control of the GFAP-, the CCK- as well as the GAD67-
promoter in adeno-associated viral backbone.
Found at: doi:10.1371/journal.pone.0004286.s002 (0.26 MB TIF)
Figure S3 Functional Cre complementation of oligodendrocytes
but also of neurons and astrocytes in PLP-NCre x PLP-CCre mice.
Fixed brain slices of PLP-NCre (line PCND) x PLP-CCre (line
PCCR) - mice were analysed for recombination using the ROSY-
reporter allele (A, E, H, K, O, R) and counterstained using
antibodies against CC1 (B, L), NeuN (F, P) and GFAP (I, S) as
markers for oligodendrocytes, neurons and astrocytes, respectively.
To compare the pattern of recombination, slice of PLP-Cre x
ROSY-mice stained for the reporter EYFP are shown in D and N.
Shown are images from the cortex (A–J) and the CA1-region of the
hippocampus (K–T). Arrows highlight cells, which show recom-
bination and are positive for the respective marker protein. The
scale bar in T corresponds to 50 mm and applies to all panels.
Found at: doi:10.1371/journal.pone.0004286.s003 (6.81 MB TIF)
Figure S4 Stable pattern of recombination in PLP-promoter
driven transgenic animals between different mouse lines. Different
lines of PLP-NCre mice (PCNA, PCND) were crossed to different
lines of PLP-CCre mice (PCCK, PCCR) and recombination was
analysed using the ROSY reporter allele by EYFP-immunostain-
ing in different brain regions. left column: line PCNA x PCCK.
2nd column: line PCND x PCCK. 3rd column: line PCNA x
PCCR. The fourth possible combination (PCCD x PCCR) is
already shown in Fig. 1 and Supporting Fig. 3. For comparison,
recombination using PLP-Cre-mice is shown in the right column.
The pattern of recombination in the cortex (ctx), hippocampus
(hc), corpus callosum (cc), cerebellum (cb), cerebellar white matter
(cb WM) as well as in the striatum (str) is similar in all four
combinations, showing recombination in oligodendrocytes, astro-
cytes and neurons. However, there are differences in the amount
of reporter-labeled cells in the different combinations. The scale
bar in X corresponds to 50 mm and applies to all panels.
Found at: doi:10.1371/journal.pone.0004286.s004 (4.61 MB TIF)
Figure S5 Widespread Cre complementation in astrocytes,
neurons and oligodendrocytes of GFAP-NCre x GFAP-CCre
mice. Fixed brain slices of GFAP-NCre (line GCNV) x GFAP-
CCre (line GCCF) - mice were analysed for recombination using
the ROSY-reporter allele (A, D, G, J, M, P) and counterstained
using antibodies against NeuN (B), S100b (E, H, K) and CC1 (N,
Q) as markers for neurons, astrocytes and oligodendrocytes,
respectively. Shown are images from the cortex (A–F), cerebellum
(G–I), hippocampus (J–L), thalamus (M–O) and midbrain (P–R).
Arrows highlight cells, which show recombination and are positive
for the respective marker protein, while arrowheads mark
reporter-labeled cells negative for the marker protein counter-
stained. The scale bar in R corresponds to 50 mm and applies to
all panels.
Found at: doi:10.1371/journal.pone.0004286.s005 (5.55 MB TIF)
Figure S6 In GFAP-NCre x PLP-CCre-mice astrocytes are the
main population of cells with Cre complementation. Transgenic
mouse lines expressing NCre under the GFAP-Promoter (line
GCNT) and CCre under the control of the PLP-Promoter (line
PCCR) were crossed to ROSY-reporter mice and analysed for
recombination (A, D, G, J, M, P). Slices were counterstained using
the astroglial marker S100b (B, K), GFAP (E, H), as well as the
oligodendroglial marker CC1 (N, Q). Overlays are shown in C, F,
I, L, O and R. The preponderant majority of cells with
recombination in these mice stain also for the astroglial markers
(examples are marked by arrows in A–L). Arrow heads highlight
reporter-labeled cells negative for the respective marker protein.
No co-localization of EYFP-expression and the oligodendroglial
marker CC1 could be found in the cerebellar white matter (M–O)
or the corpus callosum (P–R). The scale bar in R corresponds to
50 mm and applies to all panels. str: striatum; hc: hippocampus; cb
WM: cerebellar white matter; cc: corpus callosum.
Found at: doi:10.1371/journal.pone.0004286.s006 (5.61 MB TIF)
Figure S7 Functional complementation of split-Cre in vivo after
viral infection. Adeno-associated viral vectors (AAV) containing
NCre or CCre under the control of different promoters were
injected into brains of ROSY-reporter mice and recombination
was analysed by EYFP-expression. A–F: Co-injection of AAV
containing GFAP-NCre and GFAP-CCre leads to abundant
recombination in astrocytes along the injection canal and the
targeted area. The dotted line in A–C gives the location of the pia
mater, the star depicts the site of injection. The box in C indicates
the area of the higher magnification images shown in D–F which
illustrate that cells with recombination (D) are positive for the
astroglial marker GFAP (E; examples highlighted by arrows). G–
R: When using the GAD67-promoter to drive NCre as well as
CCre expression reporter-labeled interneurons were detected (G,
J), which expressed the classical interneuron marker parvalbumin
(H, K, arrows). In addition, counterstaining using the neuronal
marker NeuN (N, Q) shows that NeuN-positive cells are
recombined as analysed by expression of the reporter gene EYFP
(M, P) in the dentate gyrus (arrows). Arrowheads mark reporter-
labeled cells which are negative for the respective marker protein.
The scale bar in R corresponds to 200 mm (panel A–C) or 50 mm
(panel D–R). ctx: cortex; cc: corpus callosum; hc: hippocampus;
DG: dentate gyrus.
Split-Cre In Vivo
PLoS ONE | www.plosone.org 8 January 2009 | Volume 4 | Issue 1 | e4286Found at: doi:10.1371/journal.pone.0004286.s007 (5.86 MB TIF)
Text S1 Split-Cre in vivo: Supporting Method Details and
Tables
Found at: doi:10.1371/journal.pone.0004286.s008 (0.07 MB
DOC)
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